Skip to main content
Hit enter to search or ESC to close
Close Search
Action Santé Mondiale
  • Home
  • Identity
  • Causes
    • Fight against pandemics
    • Women and Child’s Health
    • Funding and quality of aid
    • Research and Development
    • All our causes
  • Opinions
  • Resources
  • Contact
  • French
  Research and Development

Promoting transparent and needs-driven
French R&D policies

What’s at stake?

The issue of access to medicines is at the crossroads of research, health and industrial policies. It is a global issue, with on one hand the lack of efficient, new and safe treatments for diseases affecting vulnerable populations such as Tuberculosis and on the other hand, access constraints to innovative therapies against hepatitis or cancer in both poor and rich countries.

Challenges linked to access to treatments has become a problem both for the global south and the global north, and threaten health security, health systems, social protection and patient care.

Research priorities and prices of medicines alike, are today partly defined according to industrial and trade policy considerations, at the cost of public health needs. This situation results from a historical lack of transparency of the health product market : information linked to public biomedical R&D financing, research and production costs from the pharmaceutical industry are neither available nor public. However, this data is key to define faire prices and allow citizen and their representatives to ensure good management of public financing and evaluation of R&D policies.

Our asks:

Considering budgetary restrictions and access to essential medicines being increasingly put into question even by richer countries, and, it is necessary to rethink our health systems in order to guarantee access to treatment for all. We’re asking France to:

  • Fix fair and accessible prices for molecules, including innovative ones, in order to reduce the global envelope dedicated to medicines and ensure as a result sustainability of our health finances and equitable access to health products for patients.
  • Reorient its R&D spending towards underfinanced priority public health sectors which do not represent a market opportunity such as poverty-related diseases and anti-microbial resistance.
  • Develop an ambitious accountability policy for its R&D spending, with full transparency of public funds dedicated to R&D in order to reinforce the negotiation capacity of States on the pharmaceutical market.  This accountability mechanism on traceability of public R&D funds will have to take into account all types of public financing (managed by the EU, co-managed or directly managed by France) as well as tax credits for R&D (such as the research tax credits for instance). Transparency needs to be implemented at all level : from medical research and its financing to price negotiations for health products until commercialisation.
Share Tweet Share

Global Health Advocates is a French NGO which mission is to carry out political advocacy in France and with the EU institutions to ensure policies and resources are effectively addressing health inequalities.

Adresses

Paris Office

Global Health Advocates France
176 rue du Temple
75 003 Paris

Advocacy team
Tel : +33 9 81 85 33 16
Finance & administration
info@ghadvocates.org

Brussels Office

Mundo J
Rue de l’Industrie 10
1000, Brussels

Advocacy Team
Tel: +32 (0) 2 669 42 56

Réseaux sociaux

GHA France Follow

Action Santé Mondiale/Global Health Advocates ONG de plaidoyer qui lutte pour un accès à la #santé pour tou·te·s auprès des institutions FR & UE @GHABrussels

GHAFrance
ghafrance GHA France @ghafrance ·
8 Mar

En cette journée des droits des femmes #IWD2023 ♀, @GHAFrance participe à la présentation des priorités de la diplomatie #féministe de la France 🇫🇷 par @MinColonna. On attend avec impatience le lancement de la nouvelle stratégie internationale de la France en matière de #DSSR ⚕️

Reply on Twitter 1633498972403777538 Retweet on Twitter 1633498972403777538 4 Like on Twitter 1633498972403777538 8 Twitter 1633498972403777538

GHA EU Follow

Global Health Advocates / Action Santé Mondiale Advocacy NGO that fights for #HealthforAll at the #EU level & in France @GHAFrance

GHABrussels
ghabrussels GHA EU @ghabrussels ·
9 Mar

🤝Alongside 19 partner organisations, @GHABrussels call on the @EU_Commission to publish the proposed revision of the EU 🇪🇺 #pharma legislation in March. We cannot have more delays!
See our joint letter 🔗https://www.ghadvocates.eu/joint-letter-requesting-publication-proposed-revision-eu-pharmaceutical-legislation/

Reply on Twitter 1633877856446210049 Retweet on Twitter 1633877856446210049 Like on Twitter 1633877856446210049 2 Twitter 1633877856446210049

Contact us

    © Action Santé Mondiale 2020 - Tous droits réservés - Mentions légales

    Close Menu
    • Home
    • Identity
    • Causes
      • Fight against pandemics
      • Women and Child’s Health
      • Funding and quality of aid
      • Research and Development
      • All our causes
    • Opinions
    • Resources
    • Contact
    • French